HASEGAWA Atsuhiko

J-GLOBAL         Last updated: Nov 20, 2019 at 03:05
 
Avatar
Name
HASEGAWA Atsuhiko
E-mail
hase.impttmd.ac.jp
Affiliation
Tokyo Medical and Dental University
Section
Graduate School of Medical and Dental Sciences Medical and Dental Sciences Bio-Environmental Response Immunotherapeutics
Job title
Assistant Professor
Degree
PhD (Medicine)(Tokyo Medical and Dental University)
Research funding number
90508334

Research Areas

 
 

Academic & Professional Experience

 
Jan 2008
 - 
Mar 2018
Assistant Professor, Graduate School of Medical and Dental Sciences Medical and Dental Sciences Bio-Environmental Response Immunotherapeutics, Tokyo Medical and Dental University
 
Apr 2018
 - 
Today
Assistant Professor, Graduate School of Medical and Dental Sciences Medical and Dental Sciences Bio-Environmental Response Immunotherapeutics, Tokyo Medical and Dental University
 

Education

 
Apr 1999
 - 
Mar 2003
Graduate School, Division of Medical Sciences, Tokyo Medical and Dental University
 
Apr 1993
 - 
Mar 1999
Department of Veterinary Medicine, Faculty of Agriculture, Yamaguchi University
 

Published Papers

 
Huang YL, Kawai G, Hasegawa A, Kannagi M, Masuda T
Biochemical and biophysical research communications   516(4) 1145-1151   Sep 2019
Kannagi M, Hasegawa A, Nagano Y, Kimpara S, Suehiro Y
Retrovirology   16(1) 23   Aug 2019
Kannagi M, Hasegawa A, Nagano Y, Iino T, Okamura J, Suehiro Y
Cancer science   110(3) 849-857   Mar 2019
Tax標的化ワクチンによる成人T細胞白血病の長期寛解維持 疾患予防治療としての期待(Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy)
Kannagi Mari, Hasegawa Atsuhiko, Nagano Yoshiko, Iino Tadafumi, Okamura Jun, Suehiro Youko
Cancer Science   110(3) 849-857   Mar 2019
癌免疫療法 Mitomycin C誘導性HTLV-1感染細胞死はdoxorubicin誘導性細胞死よりも樹状細胞およびマクロファージによる貪食の増強を生じさせる(Cancer immunotherapy-2 Mitomycin C-induced HTLV-1-infected cell death leads to enhanced phagocytosis by dendritic cells and macrophages compared to Doxorubicin-induced cell d
Ganbaatar Undrakh, Hasegawa Atsuhiko, Miyazawa Rinsaku, Masuda Takao, Kannagi Mari
日本免疫学会総会・学術集会記録   47(Proceedings) 3-E   Dec 2018

Misc

 
Impaired CD8+ T cell responses against human T-cell leukaemia virus type 1 in patients with adult T-cell leukaemia/lymphoma
Atsuhiko Hasegawa, Ayako Takamori, Mari Kannagi
Clinical Immunology & Allergology   62(3) 250-257   Sep 2014   [Invited]
Mari Kannagi, Atsuhiko Hasegawa, Ayako Takamori, Shuichi Kinpara, Atae Utsunomiya
Front Microbiol   3 323   2012   [Refereed]
Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis in small subsets of HTLV-1 carriers. HTLV-1-specific T-cell responses play critical roles in anti-viral an...
Mari Kannagi, Atsuhiko Hasegawa, Shuichi Kinpara, Yukiko Shimizu, Ayako Takamori, Atae Utsunomiya
Cancer Sci.   102(4) 670-676   Apr 2011   [Refereed]
Human T-cell leukemia virus type 1 (HTLV-1) is the causative retrovirus of adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-1-specific T-cell responses elicit antitumor and antiviral effects...
Mari Kannagi, Takashi Ohashi, Nanae Harashima, Shino Hanabuchi, Atsuhiko Hasegawa
Trends Microbiol.   12(7) 346-352   Jul 2004   [Refereed]
A small percentage of human T-cell leukemia virus type-I (HTLV-I)-infected individuals develop adult T-cell leukemia (ATL). In animal experiments, inoculation of HTLV-I via the oral route, which is the main route of mother-to-child viral transmiss...

Conference Activities & Talks

 
Impaired T-cell responses in natural infection of STLV-1 as a primate model of immune suppression in HTLV-1 infection
Hasegawa A, Fujikawa T, Ganbaatar U, Nagano Y, Masuda T, Tanaka Y, Akari H, Kannagi M
第77回日本癌学会学術総会   27 Sep 2018   
Tax-specific T-cell responses in allo-HSCT for ATL [Invited]
Atsuhiko Hasegawa
Seventh Annual T-cell Lymphoma Forum   Jan 2015   
CTL epitope peptide-pulsed dendritic cell vaccine has the potential to restore HTLV-1-specific CTLs to eliminate infected cells
Satomi Ando, Atsuhiko Hasegawa, Yuji Murakami, Natsuko Takatsuka, Yasuhiro Maeda, Takao Masuda, Mari Kannagi
Dec 2014   
Evaluation of anti-gp46 neutralizing monoclonal antibody vaccine against primary HTLV-1 infection to rats
Yuji Murakami, Satomi Ando, Yuetsu Tanaka, Reiko Tanaka, Takao Masuda, Mari Kannagi, Atsuhiko Hasegawa
Dec 2014   
A link between HTLV-1 leukemogenesis and innate immunity; involvement of PKR in the constitutive NFκB activation in adult T-cell leukemia cells
Shuichi Kinpara, Yasunori Saitoh, Atsuhiko Hasegawa, Masataka Nakamura, Shoji Yamaoka, Masao Matsuoka, Takao Masuda, Mari Kannagi
Dec 2014